FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148377573> ?p ?o ?g. }

• W2148377573 endingPage "547" @default.
• W2148377573 startingPage "541" @default.
• W2148377573 abstract "The in vitro contracture test (IVCT) is the only available diagnostic method at present for evaluation of malignant hyperthermia (MH) susceptibility. However, the disadvantage of the IVCT is that it is invasive. Several studies suggest that an altered inositol phosphate system is involved in the development of MH. A greater concentration of inositol 1,4,5-trisphosphate (1,4,5-IP3) was found in MH susceptible (MHS) than in normal (MHN) skeletal muscles. In this study the concentrations of 1,4,5-IP3 in blood samples and skeletal muscle specimens of identical patients were measured in an attempt to define susceptibility to MH. Muscle biopsies were obtained from 34 patients with clinical suspicion of MH. Patients were first classified as MHS (n = 19), MHN (n = 8) or MH equivocal (MHE; n = 7) by the standard IVCT. For detection of 1,4,5-IP3 concentrations, blood samples were obtained and an additional muscle specimen was excised. After sample preparation, concentrations of 1,4,5-IP3 were measured using radioimmunoassay. In blood samples, concentrations of 1,4,5-IP3 were similar in all individuals tested for MH susceptibility and in control patients not tested for MH susceptibility (n = 44). In skeletal muscle, 1,4,5-IP3 concentrations were significantly higher in MHS than in MHE or MHN patients, respectively. Each MHS sample contained more 1,4,5-IP3 than the highest concentration measured in MHN muscle. Defining arbitrary thresholds for 1,4,5-IP3 concentration in skeletal muscles in order to discriminate between MHS and MHN status, it was possible to assign three MHE patients to MHS and four to MHN. This study supports the hypothesis that an altered inositol phosphate system might be involved in MH. However, measurement of 1,4,5-IP3 concentration in a simple blood sample preparation is not reliable for MH susceptibility screening." @default.
• W2148377573 created "2016-06-24" @default.
• W2148377573 creator A5002163808 @default.
• W2148377573 creator A5002468616 @default.
• W2148377573 creator A5009433799 @default.
• W2148377573 creator A5013865521 @default.
• W2148377573 creator A5020695861 @default.
• W2148377573 creator A5058641800 @default.
• W2148377573 date "1997-05-01" @default.
• W2148377573 modified "2023-10-18" @default.
• W2148377573 title "Inositol 1,4,5-trisphosphate in blood and skeletal muscle in human malignant hyperthermia" @default.
• W2148377573 cites W1526621118 @default.
• W2148377573 cites W1549003091 @default.
• W2148377573 cites W1969581020 @default.
• W2148377573 cites W1974788242 @default.
• W2148377573 cites W1978458147 @default.
• W2148377573 cites W1979909819 @default.
• W2148377573 cites W1980166477 @default.
• W2148377573 cites W1980539305 @default.
• W2148377573 cites W1982224824 @default.
• W2148377573 cites W1986220154 @default.
• W2148377573 cites W1987719911 @default.
• W2148377573 cites W1988835380 @default.
• W2148377573 cites W1994957344 @default.
• W2148377573 cites W1995677296 @default.
• W2148377573 cites W1997367315 @default.
• W2148377573 cites W2000559906 @default.
• W2148377573 cites W2005123575 @default.
• W2148377573 cites W2006599866 @default.
• W2148377573 cites W2011031138 @default.
• W2148377573 cites W2012236671 @default.
• W2148377573 cites W2017903490 @default.
• W2148377573 cites W2017974752 @default.
• W2148377573 cites W2018729202 @default.
• W2148377573 cites W2024604910 @default.
• W2148377573 cites W2034044880 @default.
• W2148377573 cites W2035102098 @default.
• W2148377573 cites W2035672028 @default.
• W2148377573 cites W2051023487 @default.
• W2148377573 cites W2051712388 @default.
• W2148377573 cites W2052407942 @default.
• W2148377573 cites W2062771969 @default.
• W2148377573 cites W206883050 @default.
• W2148377573 cites W2070899217 @default.
• W2148377573 cites W2071686483 @default.
• W2148377573 cites W2080907632 @default.
• W2148377573 cites W2086237195 @default.
• W2148377573 cites W2092933559 @default.
• W2148377573 cites W2115694673 @default.
• W2148377573 cites W2139251346 @default.
• W2148377573 cites W2160853515 @default.
• W2148377573 cites W2164689091 @default.
• W2148377573 cites W2167174980 @default.
• W2148377573 cites W2167604030 @default.
• W2148377573 doi "https://doi.org/10.1093/bja/78.5.541" @default.
• W2148377573 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9175969" @default.
• W2148377573 hasPublicationYear "1997" @default.
• W2148377573 type Work @default.
• W2148377573 sameAs 2148377573 @default.
• W2148377573 citedByCount "15" @default.
• W2148377573 countsByYear W21483775732014 @default.
• W2148377573 countsByYear W21483775732016 @default.
• W2148377573 crossrefType "journal-article" @default.
• W2148377573 hasAuthorship W2148377573A5002163808 @default.
• W2148377573 hasAuthorship W2148377573A5002468616 @default.
• W2148377573 hasAuthorship W2148377573A5009433799 @default.
• W2148377573 hasAuthorship W2148377573A5013865521 @default.
• W2148377573 hasAuthorship W2148377573A5020695861 @default.
• W2148377573 hasAuthorship W2148377573A5058641800 @default.
• W2148377573 hasBestOaLocation W21483775731 @default.
• W2148377573 hasConcept C126322002 @default.
• W2148377573 hasConcept C134018914 @default.
• W2148377573 hasConcept C141071460 @default.
• W2148377573 hasConcept C142724271 @default.
• W2148377573 hasConcept C170493617 @default.
• W2148377573 hasConcept C185592680 @default.
• W2148377573 hasConcept C2776937108 @default.
• W2148377573 hasConcept C2777427919 @default.
• W2148377573 hasConcept C2778575482 @default.
• W2148377573 hasConcept C2778618036 @default.
• W2148377573 hasConcept C2779959927 @default.
• W2148377573 hasConcept C71924100 @default.
• W2148377573 hasConceptScore W2148377573C126322002 @default.
• W2148377573 hasConceptScore W2148377573C134018914 @default.
• W2148377573 hasConceptScore W2148377573C141071460 @default.
• W2148377573 hasConceptScore W2148377573C142724271 @default.
• W2148377573 hasConceptScore W2148377573C170493617 @default.
• W2148377573 hasConceptScore W2148377573C185592680 @default.
• W2148377573 hasConceptScore W2148377573C2776937108 @default.
• W2148377573 hasConceptScore W2148377573C2777427919 @default.
• W2148377573 hasConceptScore W2148377573C2778575482 @default.
• W2148377573 hasConceptScore W2148377573C2778618036 @default.
• W2148377573 hasConceptScore W2148377573C2779959927 @default.
• W2148377573 hasConceptScore W2148377573C71924100 @default.
• W2148377573 hasIssue "5" @default.
• W2148377573 hasLocation W21483775731 @default.
• W2148377573 hasLocation W21483775732 @default.
• W2148377573 hasOpenAccess W2148377573 @default.

• next